Researchers from across Oxford's Medical Sciences and Mathematical, Physical and Life Sciences Divisions have contributed to a new report on the future of healthcare, compiled by Citi Global Perspectives & Solutions (Citi GPS).
Among patients with atrial high-rate episodes detected by implantable devices, anticoagulation with edoxaban did not show a benefit but did increase bleeding risk in the NOAH-AFNET 6 trial.
Researchers find that targeting immune cells may help treat atrial fibrillation: New study finds that macrophages and macrophage-produced proteins contribute to heartbeat irregularities sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.
Current treatments for atrial fibrillation (AFib), a common heart condition characterized by fast and irregular beats that can lead to stroke and heart failure, have multiple side effects and are ineffective for preventing AFib recurrence.